| Autor: |
Fujii L; Department of Gastroenterology, University of Hawaii Honolulu, Hawaii, USA., Thosani NC; Center for Interventional Gastroenterology at UTHealth, McGovern Medical School, Houston, Texas, USA., Qumseya BJ; Department of Gastroenterology, Hepatology, and Nutrition, University of Florida, Gainesville, Florida, USA. |
| Abstrakt: |
Competing Interests: Disclosure All authors disclosed no financial relationships. L. Fujii-Lau has no disclosures. N. Thosani is a consultant for PENTAX of America, Inc., Ambu Inc. and Boston Scientific Corporation, and is a speaker for AbbVie Inc. B. Qumseya is a consultant for Medtronic, Inc. and Assertio Management, LLC, and is a speaker for Castle Biosciences. |
Full Text from ScienceDirect